As rates of advanced prostate cancer rise, the American Cancer Society is recommending that most men age 50 to 69 get a PSA ...
Concerns about overdiagnosis and overtreatment had driven a shift away from routine screening. But advances in clinical ...
Clarity Pharmaceuticals (ASX: CU6) ('Clarity' or 'Company'), a clinical-stage radiopharmaceutical company with a mission to ...
The American Cancer Society now recommends most men ages 50 to 69 get a PSA blood test every other year, and Black men and ...
Clarity Pharmaceuticals (ASX:CU6) has been granted FDA Breakthrough Therapy designation for 64Cu-SAR-bisPSMA for positron ...
The US Food and Drug Administration has granted 64Cu-SAR-bisPSMA its first-ever Breakthrough Therapy Designation in PSMA PET imaging, covering men with suspected biochemical recurrence of prostate ...
The American Cancer Society now recommends most men get their first PSA test when they turn 50. Black men and other men ...
One of the leading cancer organizations in the United States is raising the alarm over prostate cancer and directly urging ...
The American Cancer Society (ACS) today released an updated guideline for prostate cancer screening to help find cancer ...
Experts now recommend regular prostate cancer screening for all men ages 50 to 69 and earlier for higher-risk groups, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results